{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:45:59Z","timestamp":1765889159192,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s11033-023-08724-7","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T10:01:50Z","timestamp":1691748110000},"page":"8225-8235","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Molecular identification and biofilm formation of aerobic and anaerobic coinfection bacterial isolated from cystic fibrosis patients in southwest Iran from 2014 to 2022"],"prefix":"10.1007","volume":"50","author":[{"given":"Sasan","family":"Moogahi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fateme Tadi","family":"Beni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Hashemzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8090-2332","authenticated-orcid":false,"given":"Aram Asareh Zadegan","family":"Dezfuli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,11]]},"reference":[{"key":"8724_CR1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00622-2015","author":"SJ Simpson","year":"2015","unstructured":"Simpson SJ, Ranganathan S, Park J, Turkovic L, Robins-Browne RM et al (2015) Gram-positive bacteria progressive ventilation inhomogeneity in infants with cystic fibrosis after pulmonary infection. Eur J Respir. https:\/\/doi.org\/10.1183\/13993003.00622-2015","journal-title":"Eur J Respir"},{"key":"8724_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-007-0691-y","author":"D Matern","year":"2007","unstructured":"Matern D, Tortorelli S, Oglesbee D, Gavrilov D, Rinaldo P (2007) Reduction of the false-positive rate in newborn screening by implementation of MS\/MS-based second-tier tests: the Mayo Clinic experience. J inherit metabol dis. https:\/\/doi.org\/10.1007\/s10545-007-0691-y","journal-title":"J inherit metabol dis"},{"key":"8724_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00018-016-2391-y","volume":"74","author":"V Saint-Criq","year":"2017","unstructured":"Saint-Criq V, Gray MA (2017) Role of CFTR in epithelial physiology. Cell Mol Life Sci 74:93\u2013115. https:\/\/doi.org\/10.1007\/s00018-016-2391-y","journal-title":"Cell Mol Life Sci"},{"key":"8724_CR4","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.2147\/IDR.S204432","volume":"12","author":"A Farajzadeh Sheikh","year":"2019","unstructured":"Farajzadeh Sheikh A, Asareh Zadegan Dezfuli A, Navidifar T, Fard SS, Dehdashtian M (2019) Association between biofilm formation, structure and antibiotic resistance in Staphylococcus epidermidis isolated from neonatal septicemia in southwest Iran. Infect drug resist 12:1771\u20131782","journal-title":"Infect drug resist"},{"key":"8724_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/IDR.S197752","volume":"1","author":"HD Coutinho","year":"2008","unstructured":"Coutinho HD, Falc\u00e3o-Silva VS, Gon\u00e7alves FG (2008) Pulmonary bacterial pathogens in cystic fibrosis patients and antibiotic therapy: a tool for the health workers. Int Arch Transl Med 1:1\u20137. https:\/\/doi.org\/10.2147\/IDR.S197752","journal-title":"Int Arch Transl Med"},{"key":"8724_CR6","doi-asserted-by":"publisher","first-page":"e00019","DOI":"10.1186\/1755-7682-1-24","volume":"31","author":"MD Parkins","year":"2018","unstructured":"Parkins MD, Somayaji R, Waters VJ (2018) Epidemiology, biology, and impact of clonal Pseudomonas aeruginosa infections in cystic fibrosis. Clin microbiol rev 31:e00019-18. https:\/\/doi.org\/10.1186\/1755-7682-1-24","journal-title":"Clin microbiol rev"},{"key":"8724_CR7","doi-asserted-by":"publisher","first-page":"100831","DOI":"10.1016\/j.nmni.2020.100831","volume":"39","author":"M Hashemzadeh","year":"2021","unstructured":"Hashemzadeh M, Dezfuli AA, Nashibi R, Jahangirimehr F, Akbarian ZA (2021) Study of biofilm formation, structure and antibiotic resistance in Staphylococcus saprophyticus strains causing urinary tract infection in women in Ahvaz, Iran. New Microb New Infect 39:100831","journal-title":"New Microb New Infect"},{"key":"8724_CR8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.drup.2016.07.003","volume":"28","author":"KA Rhodes","year":"2016","unstructured":"Rhodes KA, Schweizer HP (2016) Antibiotic resistance in Burkholderia species. Drug Resist Updat 28:82\u201390. https:\/\/doi.org\/10.1016\/j.drup.2016.07.003","journal-title":"Drug Resist Updat"},{"key":"8724_CR9","unstructured":"Performance standards for (2022) Antimicrobial susceptibility testing: sixteenth informational supplement. Clinical and Laboratory Standards Institute"},{"key":"8724_CR10","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1128\/JB.00156-16","volume":"198","author":"KL Visick","year":"2016","unstructured":"Visick KL, Schembri MA, Yildiz F, Ghigo JM (2016) Biofilms 2015: multidisciplinary approaches shed light into microbial life on surfaces. J Bacteriol 198:2553\u20132563. https:\/\/doi.org\/10.1128\/JB.00156-16","journal-title":"J Bacteriol"},{"key":"8724_CR11","doi-asserted-by":"publisher","first-page":"e00138","DOI":"10.1128\/CMR.00138-18","volume":"32","author":"S Malhotra","year":"2019","unstructured":"Malhotra S, Hayes D Jr, Wozniak DJ (2019) Cystic fibrosis and Pseudomonas aeruginosa: the host-microbe interface. Clin microbiol rev 32:e00138\u2013e00118. https:\/\/doi.org\/10.1128\/CMR.00138-18","journal-title":"Clin microbiol rev"},{"key":"8724_CR12","doi-asserted-by":"publisher","first-page":"e02013","DOI":"10.1128\/JCM.02013-19","volume":"58","author":"ME Collins","year":"2020","unstructured":"Collins ME, Popowitch EB, Miller MB (2020) Evaluation of a novel multiplex PCR panel compared to quantitative bacterial culture for diagnosis of lower respiratory tract infections. J clin microbiol 58:e02013\u2013e02019. https:\/\/doi.org\/10.1128\/JCM.02013-19","journal-title":"J clin microbiol"},{"key":"8724_CR13","volume-title":"Textbook of Diagnostic Microbiology","author":"CR Mahon","year":"2014","unstructured":"Mahon CR, Lehman DC, Manuselis JG (2014) Textbook of Diagnostic Microbiology. Elsevier Health Sciences, Amsterdam"},{"key":"8724_CR14","doi-asserted-by":"publisher","first-page":"805","DOI":"10.2147\/IDR.S197988","volume":"12","author":"M Amin","year":"2019","unstructured":"Amin M, Ardaneh M, Hashemzadeh M, Dezfuli AA, JafarZadeh E (2019) In vitro antibacterial effect of deconex and sodium hypochlorite against bacterial taxa isolated from dental units. Infect drug resist 12:805. https:\/\/doi.org\/10.2147\/IDR.S197988","journal-title":"Infect drug resist"},{"key":"8724_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-7364-4-3-147","volume":"4","author":"MS Doud","year":"2010","unstructured":"Doud MS, Light M, Gonzalez G, Narasimhan G, Mathee K (2010) Combination of 16S rRNA variable regions provides a detailed analysis of bacterial community dynamics in the lungs of cystic fibrosis patients. Hum Genom 4:1\u201323","journal-title":"Hum Genom"},{"key":"8724_CR16","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ijpam.2021.07.001","volume":"9","author":"H Banjar","year":"2022","unstructured":"Banjar H, Ghawi A, AlMogarri I, Alhaider S, Alomran H, Hejazi A, Alfadhel A, Khanjar S, AlAshgar M, Alghazzi A, Abanemai L (2022) First report on the prevalence of bacteria in cystic fibrosis patients (CF) in a tertiary care center in Saudi Arabia. Int J Pediatr Adolesc Med 9:108\u2013112. https:\/\/doi.org\/10.1016\/j.ijpam.2021.07.001","journal-title":"Int J Pediatr Adolesc Med"},{"key":"8724_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2180-10-38","volume":"10","author":"E Deligianni","year":"2010","unstructured":"Deligianni E, Pattison S, Berrar D, Ternan NG, Haylock RW, Moore JE, Dooley Elborn SJ, JS, (2010) Pseudomonas aeruginosa cystic fibrosis isolates of similar RAPD genotype exhibit diversity in biofilm forming ability in vitro. Bmc Microbiol 10:1\u20133","journal-title":"Bmc Microbiol"},{"key":"8724_CR18","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3389\/fcimb.2020.00173","volume":"24","author":"N Acosta","year":"2020","unstructured":"Acosta N, Waddell B, Heirali A, Somayaji R, Surette MG, Workentine ML et al (2020) Cystic fibrosis patients infected with epidemic Pseudomonas aeruginosa strains have unique microbial communities. Front Cell Infect Microbiol 24:10:173. https:\/\/doi.org\/10.3389\/fcimb.2020.00173","journal-title":"Front Cell Infect Microbiol"},{"key":"8724_CR19","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3389\/fphar.2019.00849","volume":"10","author":"S Esposito","year":"2019","unstructured":"Esposito S, Pennoni G, Mencarini V, Palladino N, Peccini L et al (2019) Antimicrobial treatment of Staphylococcus aureus in patients with cystic fibrosis. Front pharmaco 10:849. https:\/\/doi.org\/10.3389\/fphar.2019.00849","journal-title":"Front pharmaco"},{"key":"8724_CR20","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1513\/AnnalsATS.201404-166OC","volume":"11","author":"PJ Mogayzel Jr","year":"2014","unstructured":"Mogayzel PJ Jr, Naureckas ET, Robinson KA, Brady C, Guill M et al (2014) Cystic Fibrosis Foundation pulmonary guideline. Pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infection. Ann Am Thorac Soc 11:1640\u20131650. https:\/\/doi.org\/10.1513\/AnnalsATS.201404-166OC","journal-title":"Ann Am Thorac Soc"},{"key":"8724_CR21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1569-1993(02)00141-8","volume":"2","author":"TW Lee","year":"2003","unstructured":"Lee TW, Brownlee KG, Conway SP, Denton M, Littlewood JM (2003) Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros 2:29\u201334. https:\/\/doi.org\/10.1016\/S1569-1993(02)00141-8","journal-title":"J Cyst Fibros"},{"key":"8724_CR22","doi-asserted-by":"publisher","first-page":"BSR20200847","DOI":"10.1042\/BSR20200847","volume":"40","author":"E Abbasi Montazeri","year":"2020","unstructured":"Abbasi Montazeri E, Seyed-Mohammadi S, Asarehzadegan Dezfuli A, Khosravi AD, Dastoorpoor M et al (2020) Investigation of SCC mec types I\u2013IV in clinical isolates of methicillin-resistant coagulase-negative staphylococci in Ahvaz, Southwest Iran. Biosci Rep 40:BSR20200847. https:\/\/doi.org\/10.1042\/BSR20200847","journal-title":"Biosci Rep"},{"key":"8724_CR23","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1001\/jama.2010.791","volume":"303","author":"EC Dasenbrook","year":"2010","unstructured":"Dasenbrook EC, Checkley W, Merlo CA, Konstan MW, Lechtzin N, Boyle MP (2010) Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis. JAMA 303:2386\u20132392. https:\/\/doi.org\/10.1001\/jama.2010.791","journal-title":"JAMA"},{"key":"8724_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/1705814","volume":"2020","author":"GM Abebe","year":"2020","unstructured":"Abebe GM (2020) The role of bacterial biofilm in antibiotic resistance and food contamination Int. J Microbiol Biotechnol 2020:1\u201310. https:\/\/doi.org\/10.1155\/2020\/1705814","journal-title":"J Microbiol Biotechnol"},{"key":"8724_CR25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/ppul.24139","volume":"53","author":"N Akil","year":"2018","unstructured":"Akil N, Muhlebach MS (2018) Biology and management of methicillin resistant Staphylococcus aureus in cystic fibrosis. Pediatr Pulmonol 53:64\u201374. https:\/\/doi.org\/10.1002\/ppul.24139","journal-title":"Pediatr Pulmonol"},{"key":"8724_CR26","doi-asserted-by":"publisher","first-page":"10714","DOI":"10.1073\/pnas.1721270115","volume":"115","author":"A Schick","year":"2018","unstructured":"Schick A, Kassen R (2018) Rapid diversification of Pseudomonas aeruginosa in cystic fibrosis lung-like conditions. Proc Indian Natl Sci Acad B Biol Sic 115:10714\u201310719. https:\/\/doi.org\/10.1073\/pnas.1721270115","journal-title":"Proc Indian Natl Sci Acad B Biol Sic"},{"key":"8724_CR27","doi-asserted-by":"publisher","first-page":"e04061","DOI":"10.1128\/spectrum.04061-22","volume":"11","author":"KY Lu","year":"2023","unstructured":"Lu KY, Wagner NJ, Velez AZ, Ceppe A, Conlon BP, Muhlebach MS (2023) Antibiotic tolerance and treatment outcomes in cystic fibrosis methicillin-resistant Staphylococcus aureus Infections. Microbiol Spectr 11:e04061\u2013e04022. https:\/\/doi.org\/10.1128\/spectrum.04061-22","journal-title":"Microbiol Spectr"},{"key":"8724_CR28","doi-asserted-by":"publisher","first-page":"1800242","DOI":"10.1183\/13993003.00242-2018","volume":"52","author":"MS Muhlebach","year":"2018","unstructured":"Muhlebach MS, Hatch JE, Einarsson GG, McGrath SJ, Gilipin DF, Lavelle G, Mirkovic B, Murray MA, McNally P, Gotman N, Thomas SD (2018) Anaerobic bacteria cultured from cystic fibrosis airways correlate to milder disease: a multisite study. Eur J Respir 52:1800242. https:\/\/doi.org\/10.1183\/13993003.00242-2018","journal-title":"Eur J Respir"},{"key":"8724_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fcimb.2017.00039","volume":"15","author":"MF Moradali","year":"2017","unstructured":"Moradali MF, Ghods S, Rehm BH (2017) Pseudomonas aeruginosa lifestyle: a paradigm for adaptation, survival, and persistence. Front Cell Infect Microbiol 15:7\u201339. https:\/\/doi.org\/10.3389\/fcimb.2017.00039","journal-title":"Front Cell Infect Microbiol"},{"key":"8724_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/JCM.01813-19","volume":"59","author":"CS Thornton","year":"2021","unstructured":"Thornton CS, Surette MG (2021) Potential contributions of anaerobes in cystic fibrosis airways. J Clin Microbiol 59:10\u2013128. https:\/\/doi.org\/10.1128\/JCM.01813-19","journal-title":"J Clin Microbiol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-08724-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-023-08724-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-08724-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T14:27:09Z","timestamp":1695652029000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-023-08724-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,11]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["8724"],"URL":"https:\/\/doi.org\/10.1007\/s11033-023-08724-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2023,8,11]]},"assertion":[{"value":"14 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This Research involving human participants has been performed in accordance with the Helsinki Declaration of 1964, as revised in 2013. The study was approved by the Research Ethics Committee (REC) of the Ahvaz Jundishapur University of Medical Sciences [IR.AJUMS.REC.1400.242]. Written Informed Consent was obtained from all the participants. After the submission of the preliminary proposal, necessary permission for sample collection was granted. The study was accepted by the Imam Khomeini hospital data protection authority. After having read the information letter concerning the study, all respondents were asked for written consent to participate. We emphasized that participation was voluntary and that patients could withdraw from the research at any time. In addition, All procedures involving human participants have been confirming that an identified individual has provided written consent for the use of that information. In this study, the personal information of the patients, such as name, surname, ethnicity, and personal numbers, and any information that the patient did not agree to be published, was excluded from the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Informed consent\u00a0was obtained from all the participants included in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}